Tracking now
What's getting attention on Wondara right now. Coverage and Watch interest are attention — not proof.
GLP-1 medicines
4 recent stories · latest from NPR, Oct 10, 2026
Open topic →Word on the streetRetatrutide
4 recent stories · latest from The Washington Post, Oct 9, 2026
Open topic →Word on the streetSemaglutide
4 recent stories · latest from Reuters, Sep 30, 2026
Open topic →Word on the streetTirzepatide
3 recent stories · latest from STAT, Sep 30, 2026
Open topic →Word on the streetOrforglipron
4 recent stories · latest from Reuters, Sep 29, 2026
Open topic →Word on the streetPsilocybin
4 recent stories · latest from The Washington Post, Sep 17, 2026
Open topic →Getting attentionGLP-1 medicines
Hot, and we haven't assessed the evidence yet. · Editor-assessed attention
See the gap →Getting attentionOrforglipron
Hot, and we haven't assessed the evidence yet. · Editor-assessed attention
See the gap →Getting attentionPsilocybin
Hot, and we haven't assessed the evidence yet. · Editor-assessed attention
See the gap →Getting attentionRetatrutide
Hot, and we haven't assessed the evidence yet. · Editor-assessed attention
See the gap →Getting attentionSemaglutide
Hot, and we haven't assessed the evidence yet. · Editor-assessed attention
See the gap →Getting attentionTirzepatide
Hot, and we haven't assessed the evidence yet. · Editor-assessed attention
See the gap →